Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | 10.35 | 3.45 | 3.87 | 10.51 |
Depreciation/ Depletion | 1.09 | 1.07 | 1.02 | 1.04 |
Non- Cash Items | 1.12 | 1.27 | 0.59 | 0.30 |
Changesin Working Capital | 6.25 | -2.51 | -12.07 | 0.98 |
Cashfrom Operating Activities | 18.81 | 3.28 | -6.59 | 12.82 |
Capital Expenditures | -35.64 | -4.07 | -4.61 | -0.38 |
Other Investing Cash Flow Items Total | -3.03 | -1.01 | -0.73 | -3.13 |
Cashfrom Investing Activities | -38.67 | -5.08 | -5.34 | -3.51 |
Financing Cash Flow Items | -0.74 | -0.81 | -0.83 | -0.46 |
Issuance( Retirement)of Debt Net | 19.83 | -7.36 | 10.62 | 0.00 |
Cashfrom Financing Activities | 19.09 | -8.18 | 9.79 | -0.46 |
Net Changein Cash | -0.77 | -9.98 | -2.14 | 8.85 |
Cash Interest Paid | 0.74 | 0.81 | 0.83 | 0.46 |
Cash Taxes Paid | - | - | 0.00 | - |
Auro Laboratories Dividend Auro Laboratories Bonus Auro Laboratories News Auro Laboratories AGM Auro Laboratories Rights Auro Laboratories Splits Auro Laboratories Board Meetings Auro Laboratories Key Metrics Auro Laboratories Shareholdings Auro Laboratories Profit Loss Auro Laboratories Balance Sheet Auro Laboratories Q1 Results Auro Laboratories Q2 Results Auro Laboratories Q3 Results Auro Laboratories Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks